Montelukast as a controller of atopic syndrome.

Trial Profile

Montelukast as a controller of atopic syndrome.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Sep 2013

At a glance

  • Drugs Montelukast (Primary)
  • Indications Allergic asthma; Allergic conjunctivitis; Allergic rhinitis; Hypersensitivity; Urticaria
  • Focus Therapeutic Use
  • Acronyms MONTAS
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 14 Sep 2013 Last checked against European Clinical Trials Database.
    • 27 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top